Page not found

Search results

  1. Taking a bite out of Charcot-Marie-Tooth Disease

    ... types of CMT that don’t involve PMP22 at all. Schwann cells, the “bodyguards” of nerve cells, wrap around nerve fibers, providing ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  2. Rethinking drug efficacy: research aims to improve drug development

    ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... mechanisms of action in ways not achievable with any other method, thereby enhancing our understanding of the basic science behind drug ...

    sommers - 03/11/2024 - 8:54am

  3. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... data indicate that activating immune cells with this method may improve therapeutic efficacy and reduce manufacturing expenses. ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  4. Vanderbilt leads $12M effort to accelerate real-world impact of biomedical innovations through education, mentorship and funding for aspiring entrepreneurs

    ... ranked sixth in the country in adjusted gross income from technology licensing, according to the AUTM FY22 Licensing Survey, with over 60 ... a company.  BioNanovations was built on his discovery of a method to detect bacterial proteins 96 times faster than previous diagnostics. ...

    sommers - 10/23/2023 - 8:52am

  5. Vanderbilt scientists, research translation experts attend CMT Global Research Convention

    ... conference,  Margaret Read , Vanderbilt’s  Center for Technology Transfer and Commercialization  general manager for corporate ... our data and model cell line work to nervous system cells.” Since then, the CMT Research Foundation has  invested  in ...

    sommers - 10/02/2023 - 11:32am

  6. Tech Connect, Vol. 6, Issue 21: Current cancer drug discovery method flawed says VUMC study

    ... Current cancer drug discovery method flawed: VUMC study The primary method used to test ... tools and c areer and training opportunities in Technology Transfer.   The Symposium was sponsored by  The ...

    steelmk - 11/10/2016 - 7:45am

  7. Wikswo and VIIBRE team on track to build third-generation ‘self-driving lab’ with $1M from National Science Foundation

    ... professor of machine intelligence at Chalmers University of Technology in Gothenberg, Sweden, and the developer of Adam and Eve, the first ... platform, and physics graduate student Kyle Hawkins is modeling both Genesis chemostats and yeast biology. Mark Styczynski and ...

    sommers - 05/04/2022 - 10:19am

  8. Study reveals safety signal from genes that mimic drugs

    03/07/2018 Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal  Drug Safety  by researchers at...

    sommers - 03/07/2018 - 8:16am

  9. New tool may speed antibody, vaccine research

    ... immunodeficiency virus (HIV), which causes AIDS. “The method really facilitates discovery because we were able to use a much larger ... The team is hopeful that LIBRA-seq will be a transformative technology that will have a direct impact on both basic and applied research. ...

    sommers - 12/16/2019 - 3:04pm

  10. Breast Cancer Innovation Month

    ... and Death in Prostate and Breast Cancer Patients Method to Treat Breast Cancer by Targeting Cancer Stem Cells, Tumor ... Image Guidance System for Breast Cancer Surgeries RNAi Technology to Selectively Inhibit mTORC2 in Breast Cancer Quantifying ...

    steelmk - 01/26/2018 - 3:34pm